Carcinoid tumors arise from neuroendocrine cells in the gastrointestinal tract. They most commonly occur in the appendix, ileum, and rectum. While often asymptomatic, they may secrete serotonin and cause carcinoid syndrome in rare cases. Diagnosis involves urinary tests for serotonin metabolites and imaging exams. Treatment of localized tumors is surgical resection, while metastatic tumors may also require chemotherapy. Prognosis is generally good if the tumor is localized but worsens with increased size and spread.
Sites of the highest risk are the duodenum, for adenocarcinomas, and the ileum, for carcinoids and lymphomas.
In industrialized countries, small bowel cancers are predominantly adenocarcinomas;
In developing countries, lymphomas are much more common.
The incidence of small bowel cancer rises with age and has generally been higher among males than among females.
The risk factors for small bowel cancer include
Dietary factor
Cigarette smoking,
Alcohol intake,
Medical conditions -Crohn's disease, familial adenomatous polyposis, cholecystectomy, peptic ulcer disease, and cystic fibrosis.
The protective factors may include rapid cell turnover, a general absence of bacteria, an alkaline environment, and low levels of activating enzymes of precarcinogens.
Sites of the highest risk are the duodenum, for adenocarcinomas, and the ileum, for carcinoids and lymphomas.
In industrialized countries, small bowel cancers are predominantly adenocarcinomas;
In developing countries, lymphomas are much more common.
The incidence of small bowel cancer rises with age and has generally been higher among males than among females.
The risk factors for small bowel cancer include
Dietary factor
Cigarette smoking,
Alcohol intake,
Medical conditions -Crohn's disease, familial adenomatous polyposis, cholecystectomy, peptic ulcer disease, and cystic fibrosis.
The protective factors may include rapid cell turnover, a general absence of bacteria, an alkaline environment, and low levels of activating enzymes of precarcinogens.
Obstructive jaundice is one of the important surgical topics. In this playlist I have discussed the introduction, choledocholithiasis, Carcinoma Pancreas and biliary atresia. If you watch all these videos together you will become confident in Managing obstructive jaundice.
Brief description on the benign tumors of liver that includes hemangioma, focal nodular hyperplasia, regenerative nodular hyperplasia, dysplastic foci, dysplastic nodules and focal fatty change.
Obstructive jaundice is one of the important surgical topics. In this playlist I have discussed the introduction, choledocholithiasis, Carcinoma Pancreas and biliary atresia. If you watch all these videos together you will become confident in Managing obstructive jaundice.
Brief description on the benign tumors of liver that includes hemangioma, focal nodular hyperplasia, regenerative nodular hyperplasia, dysplastic foci, dysplastic nodules and focal fatty change.
Presentation by Dr Lim Hwee Yong, Medical Oncologist, National Cancer Centre Singapore, at a NET cancer awareness seminar in Singapore on 20 November 2010.
Get the facts and more details about lung carcinoid tumor in the above slides.This slide shows more information regarding lung cancer and its various details
NIH Presentation Nov 2016 Neuroendocrine Tumor Clinical TrialsCACSNETS
NIH/NCI presentation provides an overview of and NIH clinical trials. Briefing covers: 1) Overview of GI and pancreatic Neuroendocrine Tumors (NETs) /Carcinoid Cancer;
2) Treatment options for patients with advanced GI and pancreatic NETs; 3) Clinical trials for/in patients with NETs
Adrenal Gland and its Disorders with surgical management.Manish Shetty
Short and brief description of adrenal gland and its disorder.
it involves the basic anatomy, physiology and metabolism of adrenal hormones.
.Adrenal gland tumor like adrenal cortical tumor phaechromocytoma, incidentalaoma are mentioned in this PPT.
it explains the clinical symptoms, investigation and desired management of adrenal gland disorders.
2. Objectives
• Definition and Histopathology.
• Common sites; primary and secondary.
• Epidemiology.
• Classification.
• Presentation.
• Complications.
• Investigations.
• Management.
• Prognosis.
• summary.
Carcinoid Tumors
3. Definition and Histopathology
• It is malignant tumors of GIT arise from
neuroendocrine cells (enterochromaffin cells)
at the base of intestinal crypts.
• Macroscopically: small in size.
Carcinoid Tumors
4. Common Sites
• Most common primary sites; appendix, ileum
and rectum respectively.
• Mestastasis:
– Liver (larger and more yellow than the primary
lesion).
– Mesentery, peritoneum, lymph nodes.
Carcinoid Tumors
5. Epidemiology
• 1.5 per 100, 000
• most common neuroendocrine tumors
• 45-55 years
Carcinoid Tumors
7. Symptomatology:
• Most patients are asymptomatic unless
metastasized (coincidental carcinoids)
• Secrete a number of vasoactive peptides;
mostly 5-hydroxytryptamine (serotonin) result
in carcinoid syndrome.
• haemorrhage or presenting symptoms
Carcinoid Tumors
8. Carcinoid syndrome:
less than 10%
– reddish-blue cyanosis,
– flushing attacks (induced
by alcohol)
– diarrhoea,
– Borborygmi (Abdominal
cramping)
– asthmatic attacks
– Peripheral edema
– sometimes pulmonary
and tricuspid stenosis.
Carcinoid Tumors
13. Management
• Primary: resection is suffecient.
• Secondary (liver metastasis): Chemotherapy,
enucleations, of or even partial hepatectomy.
• Octreotide to antagonize serotonin effect
– Post-appendectomy !
Carcinoid Tumors
14.
15. Prognosis
• Prognosis is good if localised (grow more
slowly).
• tumor size (>2cm), histologic features, and
distant metastasis are significant factors in
predicting survival
• Follow up with tumer marker (5-HIAA) / 6-12
months.
Carcinoid Tumors
16. Summery
• Neuroendocrine cells tumor of intestine
especially the appendix. Mostly,
asymptomatic. When secrete serotonin result
in carcinoid syndrome. Serotonin metabolites
(urinary 5-HIAA) used in screening and help
in diagnosis along with CT. Primary managed
surgically and chemotherapy used in
secondary.
Carcinoid Tumors
17. References
• http://emedicine.medscape.com/article/9860
50-workup#a0720
• Bailey & Love's Short practice of surgery, 18,
illustrated.
• Clinical Surgery, Alfred Cuschieri, 2, illustrated.
• Schwartz' Principles of Surgery, 9th edition.
• http://radiographics.rsna.org/content/26/3/6
41/F35.expansion.html
Editor's Notes
the term karzinoide, or "carcinoma-like", to describe the unique feature of behaving like a benign tumor despite having a malignant appearance microscopically.The WHO now divides these growths into neuroendocrine tumors and neuroendocrine cancers. Neuroendocrine tumors are growths that look benign but that might possibly be able to spread to other parts of the body. Neuroendocrine cancers are abnormal growths of neuroendocrine cells which can spread to other parts of the body.
The tumours can produce a number of vasoactive peptides, mostcommonly 5-hydroxytryptamine (serotonin), which may be presentas 5-hydroxyindoleacetic acid (5-HIAA) in the urine duringattacks.
gurgling noise that occurs from the movements of fluid and gas in the intestines. Borborygmi
the detection of urinary 5-HIAA is the single best screening method for carcinoid tumors,
hypervascular enhanced intraluminal mass
Figure 15d. Varied appearances of small bowel carcinoid tumors. (a) CT enterogram demonstrates a submucosal carcinoid tumor (arrows) within a Meckel diverticulum. (b) CT enterogram obtained in a different patient demonstrates a carcinoid tumor (arrow) within the wall of the ileum. (c) CT enterogram obtained in a third patient shows mesenteric metastases from an ileal carcinoid tumor. Note the enhancing, star-shaped mesenteric nodule (arrowhead), with stranding of the mesentery and thickening of the adjacent small bowel wall (arrows). The segmental wall thickening may indicate either a carcinoid carpet lesion or segmental edema. (d) Coronal reformatted CT enterographic image obtained in a fourth patient demonstrates a mesenteric carcinoid tumor (arrows) with hypervascular liver metastases (arrowheads).